Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety Clinical Activity of CCX282-B in Patients With Moderate to Severe Crohn's Disease

NCT00102921 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00102921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00102921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot, Double-Blind, Placebo-Controlled, Parallel Group Study of the Safety Clinical Activity of CCX282-B in Patients With Moderate to Severe Crohn's Disease
Lead sponsor
Amgen
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2004
Completion date
December 31, 2005
Enrollment
70
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease